National Methadone Maintenance Treatment Training Centre, Yunnan Institute of Drug Abuse, Kunming, China.
Bull World Health Organ. 2013 Feb 1;91(2):130-5. doi: 10.2471/BLT.12.108951.
China's National Methadone Maintenance Treatment Programme (MMT) has expanded from eight clinics serving approximately 1000 clients to 738 clinics that have served more than 340 000 clients cumulatively in only 8 years. This has created an enormous demand for trained providers.
Human resource development and capacity building efforts have been conducted in China's National MMT Programme to create a supply of providers trained in administering MMT for opioid dependence.
From 2004 to 2007, China's National MMT Programme faced several problems: inappropriately low methadone doses, poor compliance, high concurrent drug use and high drop-out rates among clients, and little experience, little training and high turnover rates among providers.
Training programmes for individual providers and their trainers were redeveloped and expanded in 2008. Although programme performance metrics show an increase in patients' annual mean duration in treatment (93 days in 2004 versus 238 days in 2011), the increase in their mean daily methadone dose (from 47.2 mg in 2004 to 58.6 mg in 2011) is modest.
Some of the problems that can arise during the development, launch and scale-up of a major national public health effort, such as China's National MMT Programme, cannot be foreseen. Key to the programme's success so far have been the strong commitment on the part of China's government and the optimism and pragmatism of programme managers. Human resources development and capacity-building during scale-up have contributed to improved service quality in MMT treatment clinics and are critical to long-term success.
中国的国家美沙酮维持治疗方案(MMT)在短短 8 年内从最初的 8 个门诊,为大约 1000 名患者提供服务,发展到目前的 738 个门诊,共为 34 万多名患者提供了服务。这带来了对受过培训的医务人员的巨大需求。
中国的国家 MMT 方案开展了人力资源开发和能力建设工作,以培养一批熟练掌握阿片类药物依赖美沙酮维持治疗技术的医务人员。
从 2004 年到 2007 年,中国的国家 MMT 方案面临着一些问题:美沙酮剂量过低、患者顺应性差、同期药物滥用率高和脱落率高,医务人员经验不足、培训机会少、人员流动率高。
2008 年,对个别医务人员及其培训人员的培训方案进行了重新制定和扩展。尽管方案绩效指标显示患者治疗年度平均持续时间有所增加(从 2004 年的 93 天增加到 2011 年的 238 天),但他们的平均日美沙酮剂量增加(从 2004 年的 47.2 毫克增加到 2011 年的 58.6 毫克)幅度不大。
在一个主要的国家公共卫生努力的发展、启动和扩大过程中,可能会出现一些无法预见的问题,例如中国的国家 MMT 方案。到目前为止,该方案取得成功的关键是中国政府的坚定承诺和方案管理人员的乐观和务实精神。在扩大规模的过程中进行人力资源开发和能力建设,有助于提高美沙酮维持治疗诊所的服务质量,对长期成功至关重要。